Navigation

Published technology appraisals

This table lists published NICE technology appraisals. The list can be sorted by title (alphabetically), issue date and review date. You can also:

  • click the appraisal title for full details
  • click a column heading to sort the list by that column

Please note that the 'review date' is not the date when a review of it the appraisal starts, but the date NICE consults on a proposal for reviewing it. There is no guarantee that at the review date, a review will be undertaken. Appraisals which have been considered for review and where the decision has been not to carry out a review at this time are listed in static technology appraisals.

More information on the published appraisals list.

For technology appraisal guidance organised by category, use Find guidance in the main header area above.

Searching for specific technology appraisal guidance?

Published appraisals

Results 81-100 of 308

Ref Title Date Issued Review
TA104 Psoriatic arthritis - etanercept and infliximab (TA104) (replaced by TA199) Jul 2006 TBC
TA85 Renal transplantation - immuno-suppressive regimens (adults) (TA85) Sep 2004 TBC
TA84 Sepsis (severe) - drotrecogin (withdrawn) (TA84) (withdrawn) Sep 2004 TBC
TA86 Gastrointestinal stromal tumours - imatinib (TA86) Oct 2004 TBC
TA87 Osteoporosis - secondary prevention (TA87) (replaced by TA161) (withdrawn) Jan 2005 TBC
TA106 Hepatitis C - peginterferon alfa and ribavirin (TA106) Aug 2006 TBC
TA90 Vascular disease - clopidogrel and dipyridamole (TA90) (replaced by TA210) May 2005 TBC
TA146 Psoriasis - adalimumab (TA146) Jun 2008 Jul 2008
TA125 Psoriatic arthritis (moderate to severe) - adalimumab (TA125) (replaced by TA199) Aug 2007 TBC
TA92 Tooth decay - HealOzone (TA92) Jul 2005 TBC
TA103 Psoriasis - efalizumab and etanercept (TA103) Jul 2006 TBC
TA93 Colorectal cancer (advanced) - irinotecan, oxaliplatin and raltitrexed (TA93) (replaced by CG131) Aug 2005 Aug 2008
TA97 Depression and anxiety - computerised cognitive behavioural therapy (CCBT) (TA97) Feb 2006 TBC
TA134 Psoriasis - infliximab (TA134) Jan 2008 Oct 2008
TA94 Cardiovascular disease - statins (TA94) Jan 2006 TBC
TA82 Atopic dermatitis (eczema) - pimecrolimus and tacrolimus (TA82) Aug 2004 Jan 2009
TA142 Anaemia (cancer-treatment induced) - erythropoietin (alfa and beta) and darbepoetin (TA142) May 2008 TBC
TA99 Renal transplantation - immunosuppressive regimens for children and adolescents (TA99) Apr 2006 Mar 2009
TA98 Attention deficit hyperactivity disorder (ADHD) - methylphenidate, atomoxetine and dexamfetamine (review) (TA98) Mar 2006 TBC
TA118 Colorectal cancer (metastatic) - bevacizumab and cetuximab (TA118) (partially updated by TA242) Jan 2007 May 2009

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.